Figure 1. Effect of bupivacaine on intracellular ATP levels and AMPK activation.
Neuro2a cells were treated with 2(A) Intracellular levels of ATP were measured with a luminescence assay (n = 4 per group). (B) Expression of phospho-AMPKα (P-AMPKα) and AMPK following cell exposure to bupivacaine was measured by Western blotting (n = 3 per group). ***P<0.001 vs. control (not treated with bupivacaine). All post hoc pairwise comparisons were performed by Tukey's test with repeated measures one-way ANOVA.
